Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02867995 · ClinicalTrials.gov registry record · NA
Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT02867995 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 39 participants.
The verdict
NCT02867995, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether glaucoma drop aids will be cost-effective in delivery of ophthalmic medications by improving medication compliance, visual function, and even decreasing medication waste in the patient population at Boston Medical Center (BMC).
Interventions
- DEVICE Eye Drop Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2017-03-23 |
| Est. Completion | 2018-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02867995
The ClinicalTrials.gov registry entry for NCT02867995 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Eye Drop Aid is the first listed.
NCT02867995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02867995 about?
NCT02867995 is a clinical study titled "Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center". The purpose of this study is to determine whether glaucoma drop aids will be cost-effective in delivery of ophthalmic medications by improving medication compliance, visual function, and even decreasing medication waste in the patient population at Boston Medical Center (BMC).
What is the current status of trial NCT02867995?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2017-03-23. Estimated completion is 2018-03-30.
What interventions are being tested in trial NCT02867995?
The interventions under investigation include: Eye Drop Aid (DEVICE).
Who is sponsoring clinical trial NCT02867995?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.